A PHASE II TRIAL OF TAMOXIFEN AND BORTEZOMIB IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA

被引：0
|
作者：
Aregawi, Dawit [1 ]
Kreisl, Teri N. [2 ]
Innis, Ellen [3 ]
Fine, Howard A. [4 ]
机构：
[1] NCI, Neurooncol Branch, Bethesda, MD 20892 USA
[2] Columbia Univ, Neurol Inst, New York, NY USA
[3] Univ Maryland, Baltimore, MD 21201 USA
[4] NYU, Inst Canc, NYU Langone Med Ctr, New York, NY USA
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou237.6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AT-06
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
    Odia, Yazmin
    Kreisl, Teri N.
    Aregawi, Dawit
    Innis, Ellen K.
    Fine, Howard A.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 125 (01) : 191 - 195
  • [2] A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
    Yazmín Odia
    Teri N. Kreisl
    Dawit Aregawi
    Ellen K. Innis
    Howard A. Fine
    [J]. Journal of Neuro-Oncology, 2015, 125 : 191 - 195
  • [3] A phase II trial of sunitinib in patients with recurrent high-grade glioma
    Chaskis, C.
    Sadones, J.
    Michotte, A.
    Dujardin, M.
    Everaert, H.
    Neyns, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
    Franceschi, E
    Cavallo, G
    Scopece, L
    Paioli, A
    Pession, A
    Magrini, E
    Conforti, R
    Palmerini, E
    Bartolini, S
    Rimondini, S
    Esposti, RD
    Crinó, L
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (06) : 1038 - 1044
  • [5] Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
    E Franceschi
    G Cavallo
    L Scopece
    A Paioli
    A Pession
    E Magrini
    R Conforti
    E Palmerini
    S Bartolini
    S Rimondini
    R Degli Esposti
    L Crinò
    [J]. British Journal of Cancer, 2004, 91 : 1038 - 1044
  • [6] Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
    Neyns, B.
    Sadones, J.
    Joosens, E.
    Bouttens, F.
    Verbeke, L.
    Baurain, J. -F.
    D'Hondt, L.
    Strauven, T.
    Chaskis, C.
    Veld, P. In't
    Michotte, A.
    De Greve, J.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (09) : 1596 - 1603
  • [7] Phase II trial of temozolomide in children with recurrent high-grade glioma
    A. Ruggiero
    G. Cefalo
    M.L. Garré
    M. Massimino
    C. Colosimo
    G. Attinà
    I. Lazzareschi
    P. Maurizi
    V. Ridola
    G. Mazzarella
    M. Caldarelli
    C. Di Rocco
    E. Madon
    M.E. Abate
    A. Clerico
    A. Sandri
    R. Riccardi
    [J]. Journal of Neuro-Oncology, 2006, 77 : 89 - 94
  • [8] Phase II trial of temozolomide in children with recurrent high-grade glioma
    Ruggiero, A.
    Cefalo, G.
    Garre, M. L.
    Massimino, M.
    Colosimo, C.
    Attina, G.
    Lazzareschi, I.
    Maurizi, P.
    Ridola, V.
    Mazzarella, G.
    Caldarelli, M.
    Di Rocco, C.
    Madon, E.
    Abate, M. E.
    Clerico, A.
    Sandri, A.
    Riccardi, R.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2006, 77 (01) : 89 - 94
  • [9] Phase II trial of sunitinib malate in patients with temozolomide refractory recurrent high-grade glioma
    Neyns, B.
    Chaskis, C.
    Dujardin, M.
    Everaert, H.
    Sadones, J.
    Nupponen, N. N.
    Michotte, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    Rich, Jeremy N.
    Gururangan, Sridharan
    Janney, D. E.
    Friedman, Allan H.
    Friedman, Henry S.
    Reardon, David A.
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 906 - 906
12345